{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:07:11Z","timestamp":1787828831102,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"17-18","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Gesellschaft zur Erforschung der Biologie und Therapie von Tumorkrankheiten","award":["ABCMML1"],"award-info":[{"award-number":["ABCMML1"]}]},{"name":"Austrian Science Fund","award":["F4704-B20"],"award-info":[{"award-number":["F4704-B20"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00508-019-1526-1","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T06:02:51Z","timestamp":1563429771000},"page":"410-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML)"],"prefix":"10.1007","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1921-7034","authenticated-orcid":false,"given":"Klaus","family":"Geissler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Barna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gurbisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Marschon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temeida","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmir","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Borjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Jilch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Hoermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Esterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Schwarzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"N\u00f6sslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pfeilst\u00f6cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"T\u00fcchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Reisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bettelheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Machherndl-Spandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Doleschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Zach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar","family":"Weltermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Heibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Zebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Sill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Stauder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Webersinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajko","family":"Kusec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Ulsperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"\u00d6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Germing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang R.","family":"Sperr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kn\u00f6bl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"1526_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman\u00a0JW, Thiele\u00a0J, Arber\u00a0DA, et\u00a0al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937\u201351. \n                    https:\/\/doi.org\/10.1182\/blood-2009-03-209262\n                    \n                  .","journal-title":"Blood"},{"issue":"7","key":"1526_CR2","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3324\/haematol.11051","volume":"92","author":"U Germing","year":"2007","unstructured":"Germing\u00a0U, Strupp\u00a0C, Knipp\u00a0S, et\u00a0al. Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica. 2007;92(7):974\u20137. \n                    https:\/\/doi.org\/10.3324\/haematol.11051\n                    \n                  .","journal-title":"Haematologica"},{"key":"1526_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett\u00a0JM, Catovsky\u00a0D, Daniel\u00a0MT, et\u00a0al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189\u201399.","journal-title":"Br J Haematol"},{"key":"1526_CR4","volume-title":"World health organization classification of tumours. Pathology and genetics of tumours of Haematopoietic and lymphoid tissues","year":"2001","unstructured":"Jaffe\u00a0ES, Harris\u00a0NL, Stein\u00a0H, Vardiman\u00a0JW, editors. World health organization classification of tumours. Pathology and genetics of tumours of Haematopoietic and lymphoid tissues. Lyon: IARC; 2001."},{"issue":"20","key":"1526_CR5","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber\u00a0DA, Orazi\u00a0A, Hasserjian\u00a0R, et\u00a0al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. \n                    https:\/\/doi.org\/10.1182\/blood-2016-03-643544\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR6","doi-asserted-by":"publisher","first-page":"e333","DOI":"10.1038\/bcj.2015.53","volume":"5","author":"E Padron","year":"2015","unstructured":"Padron\u00a0E, Garcia-Manero\u00a0G, Patnaik\u00a0MM, et al. An international data set for CMML validates prognostic scoring systems and demonstrates a\u00a0need for novel prognostication strategies. Blood Cancer\u00a0J. 2015;5:e333. \n                    https:\/\/doi.org\/10.1038\/bcj.2015.53\n                    \n                  .","journal-title":"Blood Cancer J"},{"key":"1526_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood.V99.3.840","volume":"99","author":"F Onida","year":"2002","unstructured":"Onida\u00a0F, Kantarjian\u00a0HM, Smith\u00a0TL, et\u00a0al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a\u00a0retrospective analysis of 213 patients. Blood. 2002;99:840\u20139.","journal-title":"Blood"},{"key":"1526_CR8","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","volume":"31","author":"R Itzykson","year":"2013","unstructured":"Itzykson\u00a0R, Kosmider\u00a0O, Renneville\u00a0A, et\u00a0al. Prognostic score including gene mutations in chronic myelomonocytic leukemia. J\u00a0Clin Oncol. 2013;31:2428\u201336. \n                    https:\/\/doi.org\/10.1200\/JCO.2012.47.3314\n                    \n                  .","journal-title":"J Clin Oncol"},{"issue":"15","key":"1526_CR9","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1182\/blood-2012-08-452938","volume":"121","author":"E Such","year":"2013","unstructured":"Such\u00a0E, Germing\u00a0U, Malcovati\u00a0L, et\u00a0al. Development and validation of a\u00a0prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood. 2013;121(15):3005\u201315. \n                    https:\/\/doi.org\/10.1182\/blood-2012-08-452938\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR10","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/leu.2013.88","volume":"27","author":"MM Patnaik","year":"2013","unstructured":"Patnaik\u00a0MM, Padron\u00a0E, La Borde\u00a0RR, et al. Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes. Leukemia. 2013;27:1504\u201310. \n                    https:\/\/doi.org\/10.1038\/leu.2013.88\n                    \n                  .","journal-title":"Leukemia"},{"issue":"10","key":"1526_CR11","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","volume":"128","author":"C Elena","year":"2016","unstructured":"Elena\u00a0C, Gall\u00ec\u00a0A, Such\u00a0E, Meggendorfer\u00a0M, et\u00a0al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128(10):1408\u201317. \n                    https:\/\/doi.org\/10.1182\/blood-2016-05-714030\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.208082","author":"MM Patnaik","year":"2019","unstructured":"Patnaik\u00a0MM, Pophali\u00a0PA, Lasho\u00a0TL, et\u00a0al. Clinical correlates, prognostic impact and survival outcomes in chronic myelomonocytic leukemia patients with the JAK2V617F mutation. Haematologica. 2019. \n                    https:\/\/doi.org\/10.3324\/haematol.2018.208082\n                    \n                  .","journal-title":"Haematologica"},{"key":"1526_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/MOH.0000000000000112","volume":"22","author":"E Padron","year":"2015","unstructured":"Padron\u00a0E, Steensma\u00a0DP. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies. Curr Opin Hematol. 2015;22:163\u201370. \n                    https:\/\/doi.org\/10.1097\/MOH.0000000000000112\n                    \n                  .","journal-title":"Curr Opin Hematol"},{"key":"1526_CR14","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1182\/blood.V88.7.2480.bloodjournal8872480","volume":"88","author":"E Wattel","year":"1996","unstructured":"Wattel\u00a0E, Guerci\u00a0A, Hecquet\u00a0B, et\u00a0al. A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia: Groupe Francais des Myelodysplasies and European CMML Group. Blood. 1996;88:2480\u20137.","journal-title":"Blood"},{"key":"1526_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","volume":"10","author":"P Fenaux","year":"2009","unstructured":"Fenaux\u00a0P, Mufti\u00a0GJ, Hellstrom-Lindberg\u00a0E, International Vidaza High-Risk MDS Survival Study Group, et al. International Vidaza High-Risk MDS Survival Study Group. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study. Lancet Oncol. 2009;10:223\u201332. \n                    https:\/\/doi.org\/10.1016\/S1470-2045(09)70003-8\n                    \n                  .","journal-title":"Lancet Oncol"},{"key":"1526_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/cncr.22457","volume":"109","author":"A Aribi","year":"2007","unstructured":"Aribi\u00a0A, Borthakur\u00a0G, Ravandi\u00a0F, et\u00a0al. Activity of decitabine, a\u00a0hypomethylating agent, in chronic myelomonocytic leukemia. Cancer. 2007;109:713\u20137. \n                    https:\/\/doi.org\/10.1002\/cncr.22457\n                    \n                  .","journal-title":"Cancer"},{"key":"1526_CR17","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1002\/cncr.25759","volume":"117","author":"R Costa","year":"2011","unstructured":"Costa\u00a0R, Abdulhaq\u00a0H, Haq\u00a0B, et\u00a0al. Activity of azacitidine in chronic myelomonocytic leukemia. Cancer. 2011;117:2690\u20136. \n                    https:\/\/doi.org\/10.1002\/cncr.25759\n                    \n                  .","journal-title":"Cancer"},{"issue":"13\u201314","key":"1526_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/BF03041036","volume":"115","author":"L Ohler","year":"2003","unstructured":"Ohler\u00a0L, Geissler\u00a0K, Hinterberger\u00a0W. Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies. Wien Klin Wochenschr. 2003;115(13\u201314):537\u201346.","journal-title":"Wien Klin Wochenschr"},{"key":"1526_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1084\/jem.184.4.1377","volume":"184","author":"K Geissler","year":"1996","unstructured":"Geissler\u00a0K, Ohler\u00a0L, F\u00f6dinger\u00a0M, et al. Interleukin 10 inhibits growth and granulocyte\/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells. J\u00a0Exp Med. 1996;184:1377\u201384.","journal-title":"J Exp Med"},{"issue":"3","key":"1526_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/bjh.12756","volume":"165","author":"MM Patnaik","year":"2014","unstructured":"Patnaik\u00a0MM, Parikh\u00a0SA, Hanson\u00a0CA, Tefferi\u00a0A. Chronic myelomonocytic leukaemia: a\u00a0concise clinical and pathophysiological review. Br J Haematol. 2014;165(3):273\u201386. \n                    https:\/\/doi.org\/10.1111\/bjh.12756\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"1526_CR21","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-09-2112","volume":"16","author":"C Ricci","year":"2010","unstructured":"Ricci\u00a0C, Fermo\u00a0E, Corti\u00a0S, et\u00a0al. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant. Clin Cancer Res. 2010;16:2246\u201356.","journal-title":"Clin Cancer Res"},{"key":"1526_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0145-2126(88)90055-0","volume":"12","author":"K Geissler","year":"1988","unstructured":"Geissler\u00a0K, Hinterberger\u00a0W, Bettelheim\u00a0P, Haas\u00a0O, Lechner\u00a0K. Colony growth characteristics in chronic myelomonocytic leukemia. Leuk Res. 1988;12:373\u20137.","journal-title":"Leuk Res"},{"key":"1526_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00277-003-0743-9","volume":"83","author":"V Sagaster","year":"2004","unstructured":"Sagaster\u00a0V, Ohler\u00a0L, Berer\u00a0A, et\u00a0al. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a\u00a0novel prognostic factor for predicting short survival. Ann Hematol. 2004;83:9\u201313.","journal-title":"Ann Hematol"},{"key":"1526_CR24","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1182\/blood-2012-10-460170","volume":"121","author":"E Padron","year":"2013","unstructured":"Padron\u00a0E, Painter\u00a0JS, Kunigal\u00a0S, et al. GM-CSF-dependent pSTAT5 sensitivity is a\u00a0feature with therapeutic potential in chronic myelomonocytic leukemia. Blood. 2013;121:5068\u201377. \n                    https:\/\/doi.org\/10.1182\/blood-2012-10-460170\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR25","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.1182\/blood-2010-04-281527","volume":"116","author":"J Wang","year":"2010","unstructured":"Wang\u00a0J, Liu\u00a0Y, Li\u00a0Z, et al. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic\/monocytic precursors in a\u00a0murine model of chronic myelomonocytic leukemia. Blood. 2010;116:5991\u20136002. \n                    https:\/\/doi.org\/10.1182\/blood-2010-04-281527\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR26","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1182\/blood-2006-09-047530","volume":"109","author":"ME Van Meter","year":"2007","unstructured":"Van Meter\u00a0ME, D\u00edaz-Flores\u00a0E, Archard\u00a0JA, et al. K\u2011RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem\/progenitor cells. Blood. 2007;109:3945\u201352. \n                    https:\/\/doi.org\/10.1182\/blood-2006-09-047530\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR27","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1182\/blood-2004-10-4002","volume":"105","author":"RJ Chan","year":"2005","unstructured":"Chan\u00a0RJ, Leedy\u00a0MB, Munugalavadla\u00a0V, et al. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. Blood. 2005;105:3737\u201342. \n                    https:\/\/doi.org\/10.1182\/blood-2004-10-4002\n                    \n                  .","journal-title":"Blood"},{"key":"1526_CR28","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","volume":"103","author":"DT Le","year":"2004","unstructured":"Le\u00a0DT, Kong\u00a0N, Zhu\u00a0Y, et\u00a0al. Somatic inactivation of Nf1 in hematopoietic cells results in a\u00a0progressive myeloproliferative disorder. Blood. 2004;103:4243\u201350. \n                    https:\/\/doi.org\/10.1182\/blood-2003-08-2650\n                    \n                  .","journal-title":"Blood"},{"issue":"11","key":"1526_CR29","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/leu.2016.235","volume":"30","author":"K Geissler","year":"2016","unstructured":"Geissler\u00a0K, J\u00e4ger\u00a0E, Barna\u00a0A, et\u00a0al. Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors. Leukemia. 2016;30(11):2280\u20131. \n                    https:\/\/doi.org\/10.1038\/leu.2016.235\n                    \n                  .","journal-title":"Leukemia"},{"key":"1526_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx187","author":"S Khozin","year":"2017","unstructured":"Khozin\u00a0S, Blumenthal\u00a0GM, Pazdur\u00a0R. Real-world data for clinical evidence generation in oncology. J\u00a0Natl Cancer Inst. 2017;109(11) \n                    https:\/\/doi.org\/10.1093\/jnci\/djx187\n                    \n                  .","journal-title":"J Natl Cancer Inst"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-1526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-019-1526-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-1526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:27:39Z","timestamp":1594942059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-019-1526-1"}},"subtitle":["A\u00a0representative and useful real-life data source for further biomedical research"],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":30,"journal-issue":{"issue":"17-18","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1526"],"URL":"https:\/\/doi.org\/10.1007\/s00508-019-1526-1","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.\u00a0Geissler, E.\u00a0J\u00e4ger, A.\u00a0Barna, M.\u00a0Gurbisz, R.\u00a0Marschon, T.\u00a0Graf, E.\u00a0Graf, B.\u00a0Borjan, R.\u00a0Jilch, C.\u00a0Geissler, G.\u00a0Hoermann, H.\u00a0Esterbauer, I.\u00a0Schwarzinger, T.\u00a0N\u00f6sslinger, M.\u00a0Pfeilst\u00f6cker, H.\u00a0T\u00fcchler, R.\u00a0Reisner, T.\u00a0Sliwa, F.\u00a0Keil, P.\u00a0Bettelheim, S.\u00a0Machherndl-Spandl, B.\u00a0Doleschal, O.\u00a0Zach, A.\u00a0Weltermann, S.\u00a0Heibl, J.\u00a0Thaler, A.\u00a0Zebisch, H.\u00a0Sill, R.\u00a0Stauder, G.\u00a0Webersinke, A.\u00a0Petzer, R.\u00a0Kusec, E.\u00a0Ulsperger, B.\u00a0Schneeweiss, J.\u00a0Berger, L.\u00a0\u00d6hler, U.\u00a0Germing, W.R.\u00a0Sperr, P.\u00a0Kn\u00f6bl, U.\u00a0J\u00e4ger, and P.\u00a0Valent declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}